Abstract
A new practical route to chaetomellic acid A (ACA), based on the copper catalysed radical cyclization (RC) of (Z)-3-(2,2-dichloropropanoyl)-2- pentadecylidene-1,3-thiazinane, is described. Remarkably, the process entailed: (i) a one-pot preparation of the intermediate N-α-perchloroacyl-2-(Z)- alkyliden-1,3-thiazinanes starting from N-(3-hydroxypropyl)palmitamide, (ii) a two step smooth transformation of the RC products into ACA and (iii) only one intermediate chromatographic purification step. The method offers a versatile approach to the preparation of ACA analogues, through the synthesis of an intermediate maleic anhydride with a vinylic group at the end of the aliphatic tail, a function that can be transformed through a thiol-ene coupling. Serendipitously, the disodium salt of 2-(9-(butylthio)nonyl)-3-methylmaleic acid, that we prepared as a representative sulfurated ACA analogue, was a more competent FTase inhibitor than ACA. This behaviour was analysed by a molecular docking study.
Original language | English |
---|---|
Pages (from-to) | 348-358 |
Number of pages | 11 |
Journal | Bioorganic and Medicinal Chemistry |
Volume | 21 |
Issue number | 1 |
DOIs | |
Publication status | Published - 1 Jan 2013 |
Bibliographical note
Funding Information:We thank the Ministero dell’Istruzione, dell’Università e della Ricerca (MIUR, PRIN 20085E2LXC-004, 20085E2LXC-003), the National Institute of Health (NIH Grant GM 21328) and the EU (under the ERASMUS scheme) for financial support.
Keywords
- Chaetomellic acid A
- Farnesyl pyrophosphate
- FTase inhibitors
- Modelling studies
- Radical cyclization